149 related articles for article (PubMed ID: 8924588)
1. Oxidative metabolism of 1-(2-chloroethyl)-3-alkyl-3- (methylcarbamoyl)triazenes: formation of chloroacetaldehyde and relevance to biological activity.
Rouzer CA; Sabourin M; Skinner TL; Thompson EJ; Wood TO; Chmurny GN; Klose JR; Roman JM; Smith RH; Michejda CJ
Chem Res Toxicol; 1996; 9(1):172-8. PubMed ID: 8924588
[TBL] [Abstract][Full Text] [Related]
2. An unexpected pathway for the metabolic degradation of 1,3-dialkyl-3-acyltriazenes.
Rouzer CA; Thompson EJ; Skinner TL; Heavner PA; Bartolini WP; Mitchell K; Kurz E; Smith RH; Michejda CJ
Biochem Pharmacol; 1993 Jul; 46(1):165-73. PubMed ID: 8347127
[TBL] [Abstract][Full Text] [Related]
3. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic-fluorescent method to determine chloroacetaldehyde, a neurotoxic metabolite of the anticancer drug ifosfamide, in plasma and in liver microsomal incubations.
Huang Z; Waxman DJ
Anal Biochem; 1999 Aug; 273(1):117-25. PubMed ID: 10452807
[TBL] [Abstract][Full Text] [Related]
5. Specificity of DNA alkylation by 1-(2-chloroethyl)-3-alkyl-3-acyltriazenes depends on the structure of the acyl group: kinetic and product studies.
Smith MB; Schmidt BF; Czerwinski G; Taneyhill LA; Snyder EJ; Kline AM; Michejda CJ; Smith RH
Chem Res Toxicol; 1996 Mar; 9(2):466-75. PubMed ID: 8839051
[TBL] [Abstract][Full Text] [Related]
6. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
Wang YP; Yan J; Fu PP; Chou MW
Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
[TBL] [Abstract][Full Text] [Related]
7. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
Ress NB;
Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
[TBL] [Abstract][Full Text] [Related]
8. Microsomal metabolism of triazenylimidazoles.
Hill DL
Cancer Res; 1975 Nov; 35(11 Pt 1):3106-10. PubMed ID: 241485
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.
Springate J; Chan K; Lu H; Davies S; Taub M
In Vitro Cell Dev Biol Anim; 1999 Jun; 35(6):314-7. PubMed ID: 10476917
[TBL] [Abstract][Full Text] [Related]
10. New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity.
Storme T; Deroussent A; Mercier L; Prost E; Re M; Munier F; Martens T; Bourget P; Vassal G; Royer J; Paci A
J Pharmacol Exp Ther; 2009 Feb; 328(2):598-609. PubMed ID: 19017849
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of dimethyl heteroaromatic triazenes in the Ames test: the role of hydrophobicity and electronic effects.
Shusterman AJ; Debnath AK; Hansch C; Horn GW; Fronczek FR; Greene AC; Watkins SF
Mol Pharmacol; 1989 Dec; 36(6):939-44. PubMed ID: 2601689
[TBL] [Abstract][Full Text] [Related]
12. Activation of microsomal glutathione S-transferase and inhibition of cytochrome P450 1A1 activity as a model system for detecting protein alkylation by thiourea-containing compounds in rat liver microsomes.
Onderwater RC; Commandeur JN; Menge WM; Vermeulen NP
Chem Res Toxicol; 1999 May; 12(5):396-402. PubMed ID: 10328749
[TBL] [Abstract][Full Text] [Related]
13. Base sequence selectivity in the alkylation of DNA by 1,3-dialkyl-3-acyltriazenes.
Kroeger Smith MB; Taneyhill LA; Michejda CJ; Smith RH
Chem Res Toxicol; 1996; 9(1):341-8. PubMed ID: 8924614
[TBL] [Abstract][Full Text] [Related]
14. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
Yan J; Xia Q; Chou MW; Fu PP
Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
[TBL] [Abstract][Full Text] [Related]
16. Mutagenic and alkylating activities of 3-methyl-1-phenyltriazenes and their possible role as carcinogenic metabolites of the parent dimethyl compounds.
Malaveille C; Brun G; Kolar G; Bartsch H
Cancer Res; 1982 Apr; 42(4):1446-53. PubMed ID: 7060018
[TBL] [Abstract][Full Text] [Related]
17. Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs.
Andersson SH; Lindgren A; Postlind H
Drug Metab Dispos; 1998 Jun; 26(6):528-35. PubMed ID: 9616187
[TBL] [Abstract][Full Text] [Related]
18. Microsomal acetaldehyde oxidation is negligible in the presence of ethanol.
Wu YS; Salmela KS; Lieber CS
Alcohol Clin Exp Res; 1998 Aug; 22(5):1165-9. PubMed ID: 9726291
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of the anti-angiogenic compound SU5416.
Antonian L; Zhang H; Yang C; Wagner G; Shawver LK; Shet M; Ogilvie B; Madan A; Parkinson A
Drug Metab Dispos; 2000 Dec; 28(12):1505-12. PubMed ID: 11095590
[TBL] [Abstract][Full Text] [Related]
20. Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite.
Brüggemann SK; Radike K; Braasch K; Hinrichs J; Kisro J; Hagenah W; Peters SO; Wagner T
Cancer Chemother Pharmacol; 2006 Feb; 57(3):349-56. PubMed ID: 16133533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
